Stocks
Teladoc Health Financial Statements (TDOC) |
||||||||||
| Teladoc Healthsmart-lab.ru | % | 2023Q3 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 24.10.2023 | 27.10.2023 | 23.02.2024 | 25.04.2024 | 26.04.2024 | 26.04.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 660.2 | 660.2 | 660.5 | 646.1 | 646.1 | 2 613 | |||
| Operating Income, bln rub | -64.7 | -64.7 | -87.1 | -87.1 | -77.1 | -316.1 | ||||
| EBITDA, bln rub | ? | 40.4 | 40.4 | -257.6 | -87.1 | 23.4 | -280.9 | |||
| Net profit, bln rub | ? | -57.1 | -57.1 | -28.9 | -81.9 | -81.9 | -249.7 | |||
| OCF, bln rub | ? | 105.6 | 105.6 | 130.1 | 8.92 | 8.92 | 253.5 | |||
| CAPEX, bln rub | ? | 37.6 | 37.6 | 36.5 | 1.15 | 35.5 | 110.8 | |||
| FCF, bln rub | ? | 68.0 | 68.0 | 93.6 | 7.77 | -26.6 | 142.7 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 386.2 | 386.2 | 238.0 | 376.4 | 430.8 | 1 431 | ||||
| Cost of production, bln rub | 186.0 | 186.0 | 193.4 | 194.5 | 292.4 | 866.4 | ||||
| R&D, bln rub | 84.3 | 84.3 | 89.9 | 81.4 | 81.4 | 337.0 | ||||
| Interest expenses, bln rub | 5.65 | 5.65 | 14.4 | 5.65 | 5.65 | 31.4 | ||||
| Assets, bln rub | 4 328 | 4 328 | 4 392 | 4 321 | 4 321 | 4 321 | ||||
| Net Assets, bln rub | ? | 2 294 | 2 294 | 2 326 | 2 289 | 2 289 | 2 289 | |||
| Debt, bln rub | 1 572 | 1 572 | 1 592 | 1 580 | 1 590 | 1 590 | ||||
| Cash, bln rub | 1 031 | 1 031 | 1 124 | 1 098 | 1 098 | 1 098 | ||||
| Net debt, bln rub | 541.7 | 541.7 | 468.6 | 481.6 | 492.3 | 492.3 | ||||
| Ordinary share price, rub | 18.6 | 18.6 | 21.6 | 15.1 | 15.1 | 34.9 | ||||
| Number of ordinary shares, mln | 165.1 | 165.1 | 166.1 | 167 731 | 167.7 | 167.7 | ||||
| Market cap, bln rub | 3 070 | 3 070 | 3 579 | 2 532 734 | 2 533 | 5 854 | ||||
| EV, bln rub | ? | 3 611 | 3 611 | 4 047 | 2 533 216 | 3 025 | 6 346 | |||
| Book value, bln rub | -507 | -507 | -425 | -399 | -399 | -399 | ||||
| EPS, rub | ? | -0.35 | -0.35 | -0.17 | 0.00 | -0.49 | -1.49 | |||
| FCF/share, rub | 0.41 | 0.41 | 0.56 | 0.00 | -0.16 | 0.85 | ||||
| BV/share, rub | -3.07 | -3.07 | -2.56 | 0.00 | -2.38 | -2.38 | ||||
| EBITDA margin, % | ? | 6.12% | 6.12% | -39.0% | -13.5% | 3.63% | -10.7% | |||
| Net margin, % | ? | -8.64% | -8.64% | -4.37% | -12.7% | -12.7% | -9.56% | |||
| FCF yield, % | ? | 3.64% | 3.64% | 5.41% | 0.01% | 7.88% | 2.44% | |||
| ROE, % | ? | -174.4% | -174.4% | -9.47% | -10.2% | -10.2% | -10.9% | |||
| ROA, % | ? | -92.5% | -92.5% | -5.02% | -5.39% | -5.39% | -5.78% | |||
| P/E | ? | -0.77 | -0.77 | -16.2 | -10 869 | -10.9 | -23.4 | |||
| P/FCF | 45.2 | 27.5 | 18.5 | 10 828 | 12.7 | 41.0 | ||||
| P/S | ? | 1.19 | 1.19 | 1.38 | 967.0 | 0.97 | 2.24 | |||
| P/BV | ? | -6.05 | -6.05 | -8.42 | -6 355 | -6.36 | -14.7 | |||
| EV/EBITDA | ? | 0.92 | 0.92 | -25.1 | -9 274 | -18.6 | -22.6 | |||
| Debt/EBITDA | 0.14 | 0.14 | -2.90 | -1.76 | -3.03 | -1.75 | ||||
| R&D/CAPEX, % | 223.9% | 223.9% | 246.4% | 7 083% | 229.2% | 304.1% | ||||
| CAPEX/Revenue, % | 5.70% | 5.70% | 5.53% | 0.18% | 5.50% | 4.24% | ||||
| Teladoc Health shareholders | ||||||||||
